Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
Are there studies looking at Ra-223 and SBRT for oligometastatic disease in the setting of mCRPC?
Answer from: Radiation Oncologist at Community Practice
Yes, quite a few including one from UCLA- NCT05496959
Sign in or Register to read more
18046
Related Questions
Does long term use of 5 alpha reductase inhibitors change the way you evaluate a PSMA PET?
How do you manage LUTS in the post-prostatectomy setting?
How do you incorporate absolute percent pattern 4 (APP4) into your risk stratification, specifically your recommendation for ADT for intermediate prostate cancer?
For recurrent prostate cancer after prostatectomy with soft tissue mass in the prostate fossa, is hypofractionation an option or is standard fractionation recommended?
How do you manage significant gas in patients undergoing pelvic radiotherapy?
What are the indications for postoperative radiation for extramammary Paget's disease?
What are your top takeaways from ASCO GU 2025?
Given results of the RADICALS trials, is LT-ADT standard of care for salvage prostate RT?
When following active surveillance paradigm, what PSA increase will trigger prostate biopsy?
When do you start ADT for a patient with a new diagnosis of node positive prostate cancer receiving radiation?